NCT02409446View on ClinicalTrials.gov

Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2018

Conditions
Coronary DiseaseInflammationCognitive Impairment
Interventions
DIETARY_SUPPLEMENT

Anthocyanin

Open pilot study. 35 patients will receive anthocyanin 160 mg x 2 p.o for 16 weeks

Trial Locations (1)

Unknown

Stavanger University Hospital, Stavanger

All Listed Sponsors
lead

Helse Stavanger HF

OTHER_GOV

NCT02409446 - Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins | Biotech Hunter | Biotech Hunter